Symbol="FDMT"
AssetType="Common Stock"
Name="4D Molecular TherapeuticsÂ Inc"
Description="4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops candidate products using its adeno-associated virus vectors. The company is headquartered in Emeryville, California."
CIK="1650648"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="5858 HORTON STREET #455, EMERYVILLE, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="671842000"
EBITDA="-113816000"
PERatio="None"
PEGRatio="None"
BookValue="7.74"
DividendPerShare="0"
DividendYield="0"
EPS="-3.37"
RevenuePerShareTTM="0.067"
ProfitMargin="0"
OperatingMarginTTM="-51.4"
ReturnOnAssetsTTM="-0.224"
ReturnOnEquityTTM="-0.373"
RevenueTTM="2285000"
GrossProfitTTM="-77124000"
DilutedEPSTTM="-3.37"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.475"
AnalystTargetPrice="38.63"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="378.9"
PriceToBookRatio="3.014"
EVToRevenue="277.01"
EVToEBITDA="-5.32"
Beta="2.338"
num_52WeekHigh="26.49"
num_52WeekLow="6.58"
num_50DayMovingAverage="18.48"
num_200DayMovingAverage="18.83"
SharesOutstanding="41885400"
DividendDate="None"
ExDividendDate="None"
symbol="FDMT"
open="16.01"
high="17.02"
low="15.97"
price="16.70"
volume="348844.00"
latest_trading_day="2023-08-21"
previous_close="16.04"
change="0.66"
change_percent="4.1147%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="61"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="39"
Volume_recent_avg="507377"
Change_recent_avg="-0.01"
Delta_recent_avg="1.16"
Variance_recent_avg="0.58"
Change_ratio_recent_avg="-0.14"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_negative_10"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="39"
Aroon_momentum_negative="61"
image_negative_thumbnail_id_1="1119"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0152.jpeg"
image_negative_thumbnail_id_2="1132"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0165.jpeg"
image_neutral_thumbnail_id_1="575"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0024.jpeg"
image_neutral_thumbnail_id_2="559"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0040.jpeg"
image_positive_thumbnail_id_1="655"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0053.jpeg"
image_positive_thumbnail_id_2="656"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0052.jpeg"
image_professor_thumbnail_id_1="1181"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
image_professor_thumbnail_id_2="1172"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
